Vo Thomas T.'s Form 4 filing
Nutex Health Inc. (NUTX) · filed Sep 1, 2023
- Accession no.
- 0001486189-23-000024
- Filed
- Sep 1, 2023, 3:00 PM ET
- Trade date
- Aug 28-31, 2023
- Filing delay
- 4 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions. Open-market purchases total $296.0K. It was filed 4 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Vo Thomas T.CIK 0001919945 | Director, Officer (Chief Executive Officer), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 28, 2023 | Common Stock | PPurchaseAcquired | +198,983 | $0.28F1 | +$55,715.24 | 268,521,759 | Indirect | |
| Aug 29, 2023 | Common Stock | PPurchaseAcquired | +342,744 | $0.30F2 | +$102,823.2 | 268,864,503 | Indirect | |
| Aug 30, 2023 | Common Stock | PPurchaseAcquired | +305,947 | $0.31F3 | +$94,843.57 | 269,170,450 | Indirect | |
| Aug 31, 2023 | Common Stock | PPurchaseAcquired | +152,326 | $0.28F4 | +$42,651.28 | 269,322,776 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions with prices ranging from $0.28 to $0.29, inclusive. The reporting person undertakes to provide to Nutex Health Inc., any security holder of Nutex Health Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range of footnote (1) to this Form 4.
Referenced by the price of 1 transaction in Table I.
- F2
The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions with prices ranging from $0.29 to $0.33, inclusive. The reporting person undertakes to provide to Nutex Health Inc., any security holder of Nutex Health Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range of footnote (2) to this Form 4.
Referenced by the price of 1 transaction in Table I.
- F3
The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions with prices ranging from $0.30 to $0.33, inclusive. The reporting person undertakes to provide to Nutex Health Inc., any security holder of Nutex Health Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range of footnote (3) to this Form 4.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions with prices ranging from $0.27 to $0.30, inclusive. The reporting person undertakes to provide to Nutex Health Inc., any security holder of Nutex Health Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range of footnote (4) to this Form 4.
Referenced by the price of 1 transaction in Table I.